Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
42.46B | 40.02B | 32.27B | 21.13B | 18.29B | 40.42B | Gross Profit |
5.04B | 3.25B | 1.22B | -3.98B | -8.57B | 4.56B | EBIT |
1.77B | 90.00M | -1.32B | -6.46B | -11.24B | 3.00M | EBITDA |
2.72B | 1.72B | 104.00M | -3.92B | -7.86B | 1.81B | Net Income Common Stockholders |
2.82B | 912.00M | 73.00M | -4.99B | -10.07B | -400.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.93B | 8.65B | 6.14B | 6.44B | 16.06B | 11.04B | Total Assets |
23.90B | 23.55B | 21.37B | 20.09B | 32.77B | 29.47B | Total Debt |
3.64B | 5.78B | 3.58B | 4.93B | 10.90B | 9.17B | Net Debt |
-6.29B | -2.88B | -2.56B | -1.50B | -5.17B | -1.88B | Total Liabilities |
19.03B | 20.34B | 19.61B | 18.73B | 26.49B | 22.72B | Stockholders Equity |
4.87B | 3.22B | 1.76B | 1.36B | 6.28B | 6.75B |
Cash Flow | Free Cash Flow | ||||
0.00 | 174.00M | -74.00M | -5.27B | -4.13B | 4.28B | Operating Cash Flow |
0.00 | 529.00M | 122.00M | -5.23B | -3.72B | 4.89B | Investing Cash Flow |
0.00 | -267.00M | -159.00M | 1.07B | 520.00M | -1.92B | Financing Cash Flow |
0.00 | 2.17B | -356.00M | -5.72B | 9.04B | 1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $1.29T | 12.04 | 11.26% | 3.26% | 11.64% | 12.12% | |
73 Outperform | ¥7.09B | 7.40 | 2.00% | 1.73% | -61.62% | ||
72 Outperform | ¥1.35T | 8.84 | 2.08% | 10.02% | -2.91% | ||
69 Neutral | ¥7.91B | 7.28 | 0.48% | 2.99% | 2.08% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
62 Neutral | ¥8.26B | 4.12 | ― | 7.20% | 104.01% |